Telomir-Zn is designed to rebalance intracellular iron and copper, inhibiting enzymes that cancer cells use to silence tumor-suppressor genes. This mechanism is intended to help restore normal gene regulation. Telomir-Zn is investigational and not yet approved by the FDA.